2022 - Research.com Microbiology in Australia Leader Award
2016 - Fellow of the Australian Academy of Health and Medical Science
Gregory J. Dore mainly investigates Hepatitis C, Hepatitis C virus, Internal medicine, Immunology and Virology. His research in Hepatitis C intersects with topics in Cirrhosis, Viral load, Transmission, Liver disease and Ribavirin. The study incorporates disciplines such as Alpha interferon and Pharmacology in addition to Ribavirin.
The various areas that Gregory J. Dore examines in his Hepatitis C virus study include Seroconversion, Disease burden, Public health and Intensive care medicine. His Internal medicine study integrates concerns from other disciplines, such as Surgery, Gastroenterology, Acquired immunodeficiency syndrome, Sofosbuvir and Coinfection. Gregory J. Dore interconnects Genotype, Incidence and Disease in the investigation of issues within Immunology.
His primary areas of investigation include Hepatitis C, Internal medicine, Hepatitis C virus, Virology and Immunology. His Hepatitis C research is multidisciplinary, relying on both Epidemiology, Viral load, Liver disease, Hepacivirus and Drug. His work in Internal medicine addresses issues such as Ribavirin, which are connected to fields such as Alpha interferon.
His Hepatitis C virus research incorporates elements of Incidence, Intensive care medicine, Transmission, Hepatocellular carcinoma and Genotype. Particularly relevant to Virus is his body of work in Virology. As part of his studies on Immunology, Gregory J. Dore frequently links adjacent subjects like Acquired immunodeficiency syndrome.
Gregory J. Dore spends much of his time researching Internal medicine, Hepatitis C, Hepatitis C virus, Incidence and Virology. His studies examine the connections between Internal medicine and genetics, as well as such issues in Gastroenterology, with regards to Dried blood spot. The Hepatitis C study which covers Hepatocellular carcinoma that intersects with Liver disease, Improved survival and Carcinoma.
Many of his research projects under Hepatitis C virus are closely connected to World health with World health, tying the diverse disciplines of science together. His Incidence research is multidisciplinary, incorporating elements of Treatment as prevention, Confidence interval, Hcv transmission, Prospective cohort study and Pediatrics. In his study, Venipuncture is strongly linked to Cohort study, which falls under the umbrella field of Viral load.
Hepatitis C, Hepatitis C virus, Internal medicine, Sofosbuvir and Cirrhosis are his primary areas of study. His work carried out in the field of Hepatitis C brings together such families of science as Ombitasvir, Dasabuvir, Ritonavir, Paritaprevir and Drug. His Hepatitis C virus study results in a more complete grasp of Virology.
His Virology research includes elements of Haplotype and DNA sequencing. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Ribavirin. Gregory J. Dore focuses mostly in the field of Incidence, narrowing it down to matters related to Prospective cohort study and, in some cases, Men who have sex with men, Female sex, Survival analysis and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
Vijayaprakash Suppiah;Max Moldovan;Golo Ahlenstiel;Thomas Berg.
Nature Genetics (2009)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.
J M Micallef;J M Kaldor;G J Dore.
Journal of Viral Hepatitis (2006)
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh;Jason Grebely;Gregory J. Dore.
Nature Reviews Gastroenterology & Hepatology (2013)
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression†
Hla-Hla Thein;Hla-Hla Thein;Qilong Yi;Gregory J. Dore;Murray D. Krahn;Murray D. Krahn.
Hepatology (2008)
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
Anthony J. Freeman;Gregory J. Dore;Matthew G. Law;Max Thorpe.
Hepatology (2001)
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals
Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard.
Hepatology (2013)
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
Gregory J. Dore;Patricia K. Correll;Yueming Li;John M. Kaldor.
AIDS (1999)
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
Hla-Hla Thein;Qilong Yi;Gregory J Dore;Murray D Krahn.
AIDS (2008)
Global burden of disease (GBD) for hepatitis C
Y Hutin;ME Kitler;GJ Dore;JF Perz.
JOURNAL OF CLINICAL PHARMACOLOGY , 44 (1) pp. 20-29. (2004) (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
UNSW Sydney
UNSW Sydney
Burnet Institute
UNSW Sydney
Macquarie University
UNSW Sydney
UNSW Sydney
University of Sydney
UNSW Sydney
UNSW Sydney
University of Trento
Umeå University
Tsinghua University
University of North Texas
Kansas State University
Shanghai Jiao Tong University
University of Zurich
University of Lausanne
Oswaldo Cruz Foundation
Osaka University
Federal University of Rio de Janeiro
Oswaldo Cruz Foundation
National Institutes of Health
University of Michigan–Ann Arbor
University of East Anglia
Washington University in St. Louis